Medical News

RSS

Transcendental Meditation may reduce symptoms of depression

The Transcendental Meditation- technique may be an effective approach to reduce symptoms of depression, according to two new studies to be presented at the 31st Annual Meeting of the Society of Behavioral Medicine in Seattle, Washington April 9th, 2010.

8 Apr 2010

Encouraging results from OptiNose's sumatriptan Phase II study for migraine

OptiNose, a leader in nasal drug delivery systems, is pleased to announce the publication in Cephalalgia of results from its Phase II clinical study investigating the efficacy and tolerability of its novel, intranasal drug/device product for the treatment of migraine.

8 Apr 2010

Women need to be educated on osteoporosis risk factors and treatment: Study

Underscoring what researchers call a serious global public health concern, results from a new study led by Columbia University Medical Center reveal that many women at an elevated level of risk for osteoporosis-associated fractures fail to perceive the implications of the risk factors.

8 Apr 2010

FDA approves Mylan Pharmaceuticals' generic NuLytely laxative

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution (with Flavor Packs), the generic version of Braintree Laboratories' NuLytely® laxative.

8 Apr 2010

Innovative algorithms lead to new arena of breast ultrasound technology

The groundbreaking algorithms developed at TechniScan, Inc. have led to a new arena of whole breast ultrasound technology, as presented at a national medical ultrasound conference in San Diego in March.

8 Apr 2010

Uncertainties remain about health law

McClatchy/Miami Herald: "Two weeks after President Barack Obama signed the big health care overhaul into law, Americans are struggling to understand how — and when — the sweeping measure will affect them. Questions reflecting confusion have flooded insurance companies, doctors' offices, human resources departments and business groups." One insurance agent said consumers are asking, "Where do we get the free Obama care, and how do I sign up for that?" (Taley, 4/6).

8 Apr 2010

Oraya Therapeutics' IRay stereotactic radiotherapy system granted European CE Mark approval

Oraya Therapeutics, Inc. announces today that a leading European notified body has granted approval to designate the CE mark to Oraya's IRayTM stereotactic radiotherapy system. Under development since 2007, the IRay is designed specifically to treat diseases of the eye, and the technology enables precise delivery of low energy X-rays for the treatment of wet age-related macular degeneration (AMD).

8 Apr 2010

Health reform's Medicaid expansion, payment increase causes mixed feelings for MDs

Kaiser Health News reporter Maggie Mertens writes: "While doctors are worrying a lot about whether Congress will block the 21 percent scheduled cut in Medicare payments, a fix to another public health program is raising another question" (Mertens, 4/6).

8 Apr 2010

Ultrasound scan of carotid artery improves prediction of heart disease: Research

New research shows that doing a simple ultrasound scan of the carotid artery significantly improves the prediction of heart disease, giving doctors a better clue of who is at high risk for a heart attack.

8 Apr 2010

Medical community and MPs react to deaths caused by inept foreign doctors

German doctor Daniel Ubani accidentally killed patient David Gray on his first UK shift as an out-of-hours locum GP. The death of the man aged 70 occurred from an overdose of diamorphine administered by Ubani whose poor English skills are being blamed. This has lead to a strong reaction from the local medical community and the MPs.

8 Apr 2010

Researchers discover two genetic regions that influence birth weight

New research uncovers two genetic regions that influence birth weight. One of the regions is also associated with type 2 diabetes, which helps to explain why small babies have higher rates of diabetes in later life.

8 Apr 2010

MAP Pharmaceuticals initiates PD trial comparing LEVADEX to IV DHE

MAP Pharmaceuticals, Inc. today announced that the Company initiated a pharmacodynamics (PD) trial to compare the acute effect of LEVADEX™ orally inhaled migraine therapy to intravenous dihydroergotamine mesylate (IV DHE) and placebo on pulmonary artery pressure as measured by echocardiography.

8 Apr 2010

Massachusetts insurers close plans, leaving would-be customers in limbo

An ongoing showdown between Massachusetts regulators and the insurance industry resulted in insurers temporarily closing plans to new enrollees Tuesday.

8 Apr 2010

New Life MicroFab Division launched to provide micro-fabrication services

Life BioScience, Inc. has launched a new Life MicroFab™ Division that provides a broad range of micro-fabrication services for devices made in APEX Glass, APEX Ceramic, Silicon, Pyrex, SOI, Kapton and other standard materials used in the semiconductor manufacturing process.

8 Apr 2010

Ease up on the drink! New NZ ad campaign targets drinking buddies

“Hitting the bottle is not the cure to the ills of the world” was the last message from the advertisements of New Zealand’s Alcohol Advisory Council (ALAC). That campaign focused on graphic examples of excessive drinking leading to harm, with three realistic characters who made poor and dangerous choices.

8 Apr 2010

Avid Radiopharmaceuticals, PETNET Solutions collaborate in manufacture of Florbetapir F 18

Avid Radiopharmaceuticals, Inc. and PETNET Solutions, Inc., a wholly-owned subsidiary of Siemens Medical Solutions, USA, Inc., marked the first dose shipped from a PETNET Solutions manufacturing facility as part of its collaboration with Avid on Florbetapir F 18 (18F-AV-45 or Florbetapir), Avid's molecular imaging agent for positron emission tomography (PET) imaging of β-amyloid deposits in the brain, a key pathological component of Alzheimer's disease.

8 Apr 2010

Scientists discover how mechanical stress promotes new bone growth

For osteoporosis patients unable to exercise, help may be on the way. That's because scientists have discovered precisely how mechanical stress, such as exercise, promotes new bone growth. This opens the door to entirely new therapies that can trick bones into thinking they are getting a workout. The research report describing this advance is published online in The FASEB Journal.

8 Apr 2010